Thank you for your interest in our upcoming events! If you have any questions or want to setup a meeting, please reach out to our team.
Curi Bio’s Korea team will be attending Bio Korea 2026!
Please fill out the form below to setup a meeting.
Curi Bio’s Dr. Mohammad Khoonkari will be attending Olympiad in Cardiovascular Medicine 2026!
Please fill out the form below to setup a meeting.
Curi Bio’s Dr. Hamed Ghazizadeh will be attending ISCT 2026!
Please fill out the form below to setup a meeting.
Curi Bio’s Dr. Nelsa Estrella will be attending ASGCT 2026!
Visit the team at Booth #701!
Please fill out the form below to setup a meeting.
Curi Bio’s team will be exhibiting at MPS World Summit 2026!
Visit the team at our Booth!
Please fill out the form below to setup a meeting.
Curi Bio is heading to Finland!
The Curi Bio team, Hamed Ghazizadeh and Mohammad Khoonkari will be in Helsinki, Finland from April 24th – 27th.
Hamed Ghazizadeh
Mohammad Khoonkari
Please fill out the form below to setup a meeting.
Curi Bio’s CBO and Co-founder, Elliot Fisher, will be presenting at Life Science Innovation Northwest 2026!
Please fill out the form below to setup a meeting.
Curi Bio is heading to Germany!
The Curi Bio team, Hamed Ghazizadeh and Mohammad Khoonkari will be in South Germany and in Berlin from April 20th – 24th.
Hamed Ghazizadeh
Mohammad Khoonkari
Please fill out the form below to setup a meeting.
The Neuromuscular Junction (NMJ) is the critical electrophysiological interface between motor neurons and skeletal muscle, and its proper function is vital to human health. Functional disruptions at this synapse are central to debilitating genetic diseases like ALS, SMA, and Myasthenia Gravis, as well as the effects of life-threatening neurotoxins. Historically, researchers have had to choose between animal models which are limited by species-specific physiology and simplified 2D cultures that lack the structural and functional complexity of human tissues. This persistent translational gap has slowed therapeutic discovery and limited the reliability of potency testing.
In this webinar, Curi Bio introduces a human 3D engineered neuromuscular junction platform designed to overcome these limitations. Built on the Mantarray™ ecosystem, this human-relevant system integrates iPSC-derived motor neuron neurospheres with 3D engineered skeletal muscle tissues in a scalable 24-well format. The platform enables rapid assembly of functional neuromuscular co-cultures within approximately 3 weeks, making advanced tissue models accessible without specialized tissue-engineering expertise.
We will delve into the technical innovations driving this platform, including:
Optogenetic Functional Sensing: How blue-light activation of motor neurons enables real-time, specific measurement of synaptic transmission and neuron-mediated muscle contraction.
Structural Maturity: Evidence from immunohistochemistry showing in mature morphology, including co-localization of axons, myotubes, and acetylcholine receptors.
Innervation-Driven Maturation: RNA-seq transcriptomics and force-frequency data demonstrating that innervation drives advanced skeletal muscle maturity and MyHC isoform shifts.
High-Throughput Potency Assays: Validation of the system as a robust, ethical alternative to animal lethality tests, with Botulinum neurotoxin (BoNT) potency measurements showing superior sensitivity and minimal variability.
Flexible Disease Modeling: Lentiviral delivery of Channelrhodopsin-2 enables rapid integration of diverse motor neuron cell lines, facilitating scalable modeling of neuromuscular diseases such as ALS and SMA.
Join Dr. Jacob W. Fleming and Dr. Thomas Leahy to learn how you can leverage these advanced 3D neuromuscular junction models to generate decision-driving data for your research and therapeutic discovery pipelines.
Wednesday, April 15, 2026 at 8:00-9:00am PDT (11:00am EDT / 5:00pm CEST)
Curi Bio is heading to Denmark and Sweden!
The Curi Bio team, Hamed Ghazizadeh, Christos Michas, and Travis Moerk will be in Denmark and Sweden from April 7th – 9th.
Hamed Ghazizadeh
Christos Michas
Travis Moerk
Please fill out the form below to setup a meeting.
Curi Bio’s Dr. Hamed Ghazizadeh and Dr. Mohammad Khoonkari will be sponsoring and presenting at the Lama-2 Conference 2026!
Please fill out the form below to setup a meeting with a Curi Bio team member.
Curi Bio’s Dr. Greg Luerman will be presenting at the ORS 2026 Annual Meeting!
Please fill out the form below to setup a meeting with a Curi Bio team member.
Curi Bio’s Dr. Nicholas Geisse will be presenting at the 2026 Next-Wave Obesity Therapeutics & Drug Development Summit Europe Meeting!
Please fill out the form below to setup a meeting with Dr. Geisse in Barcelona.
Curi Bio team members, Dr. Nicholas Geisse, Elliot Fisher, Bryan Koci, and Dr. Christal Worthen, will be exhibiting at the 2026 SOT Annual Meeting!
Please fill out the form below to setup a meeting with a Curi Bio team member.
In this free live webinar, we will cover:
Human-Relevant Maturity: Learn how 3D bioengineered tissues reach a stable, adult-like metabolic and structural state by day 21.
Predictive Metabolic Function: Explore breakthroughs in capturing robust insulin-stimulated glucose uptake and mature GLUT4 localization for diabetes research.
Exercise Physiology In Vitro: See how exercise-mimicking stimulation and detraining mirror real-world human muscle plasticity and reversibility.
New Biological Insights: Discover the role of GYS1 and glycogen metabolism in sustaining muscle endurance under metabolic stress.
Join this webinar for the opportunity to learn more and join the live Q&A.
The translational gap between animal models and human clinical outcomes often stems from fundamental interspecies differences in fiber composition and metabolic regulation. This webinar features a landmark study from Novo Nordisk and the University of Copenhagen, utilizing Curi Bio’s Mantarray 3D skeletal muscle ecosystem.
We will detail a comprehensive workflow for generating functionally mature human muscle tissues that stabilize for longitudinal study. By integrating physiological, pharmacological, and genetic perturbations, the research team demonstrated that these tissues not only mirror human-like responses to insulin and exercise but also reveal new mechanisms of metabolic resilience. This session will provide a roadmap for using New Approach Methodologies (NAMs) to advance drug discovery for obesity, diabetes, and neuromuscular diseases.
Wednesday, March 18, 2026 at 8:00-9:00am PT (11:00am ET / 5:00pm CET)
Curi Bio is heading to London! 💂
Our Business Development team, Hamed Ghazizadeh and Mohammad Khoonkari will be in London from March 16th – 20th. At Curi Bio, we believe that world-class science deserves a personalized, white-glove approach to partnership.
Hamed Ghazizadeh
Mohammad Khoonkari
While Hamed connects with the community at the Advanced Therapies conference, Mohammad will be visiting with local partners throughout the city. They are both available for 1:1 sessions and technical consultations to discuss how Curi Bio’s 3D human-relevant discovery platforms are redefining the path to the clinic.
Whether you’re interested in a deep dive into our Mantarray™ platform for 3D muscle contractility or exploring our full end-to-end ecosystem of cells and AI-driven analytics, we want to hear about your specific drug discovery goals.
Let’s bridge the gap between bench top discovery and clinical potential together.
Are you based in London or attending Advanced Therapies?
Please fill out the form below to setup a meeting.
Curi Bio team members, Dr. Hamed Ghazizadeh and Dr. Mohammad Khoonkari, will be at the Dutch-German Joint Meeting in Amsterdam! Come visit us at our booth and meet with Hamed Ghazizadeh and Mohammed Khoonkari to explore our scalable solutions for cardiovascular research. Plus, don't miss our sponsored talk on Friday, March 13th!
Please fill out the form below to setup a meeting with a Curi Bio team member.
Curi Bio team members, Dr. Nicholas Geisse, Elliot Fisher, Dr. Nelsa Estrella, Dr. Christal Worthen, and Dr. Greg Luerman, will be at MDA 2026 in Orlando, FL!
Oral Presentation
Title: Beyond 2D: Utilizing Curi Bio’s 3D Engineered Muscle Tissue for Predictive Disease Modeling
Presented By: Dr. Nicholas Geisse
March 9, 4-6p, Orange ABC
Poster Presentation
Title: Dystrophin Deficiency Attenuates Fibroadipogenic Progenitor–Mediated Contractile Maturation in 3D Engineered Muscle Tissues
Poster Presentation
Title: Modeling MYBPC3-Driven Hypertrophic Cardiomyopathy Using Human 3D Engineered Heart Tissues
Poster Presentation
Title: Innervation Induces a Distinct Force–Frequency Phenotype in 3D Human Neuromuscular Junction Tissues
Please fill out the form below to setup a meeting with a Curi Bio team member at MDA 2026.
Curi Bio is proud to participate in the 27th NIH Tissue Chip Consortium Meeting & C-Path Public Workshop at the National Cancer Institute. We’ll be in the DC area from Thursday through Saturday, connecting the dots between our mission, providing human data for next-generation medicines, and the critical regulatory frameworks being established by the NIH and C-Path’s Predictive Safety Testing Consortium.
Our CEO, Nicholas Geisse, will be a featured speaker at the event! He will be speaking on Day 1 (March 5). Nicholas will be presenting on Curi Bio’s BoNT (Botulinum Neurotoxin) assay, showcasing how our 3D Neuromuscular Junction (NMJ) models are advancing functional, human-relevant safety and efficacy testing.
Our CBO, Elliot Fisher, will also be attending and ready to discuss how our 3D ecosystems and workflow are helping partners reduce preclinical risk to make data-driven "Go/No-Go" decisions sooner, maximizing the impact of your R&D investment.
Day 1 (March 5): Defining "Context of Use" and evidentiary standards, essential steps for making Microphysiological Systems (MPS) a regulatory standard.
Day 2 (March 6): The integration of In-Silico NAMs and tissue chips, the powerful synergy that is reshaping the industry.
🤝 Let's Connect! Please fill out the form below to request a meeting with Nick and/or Elliot.
Traditional 2D models often fail to predict human clinical outcomes, creating a costly translation gap in drug discovery. Join us as we demonstrate how to bridge this gap using the Pulse™ Analysis Software on data collecting using the Curi Bio ecosystem of products, including Mantarray and Nautilai. We will explore how to seamlessly transform raw data into advanced functional parameters—characterizing twitch and tetanic contractions as well as calcium and voltage transients—using a turn-key platform designed for speed and confidence.
Curi Bio team member, Dr. Hamed Ghazizadeh, will be presenting at WORD+ 2026 in Hinxton, UK!
Poster Presentation
Title: A Scalable Human Neuromuscular Junction Platform for Neurotoxin Potency Testing, Skeletal Muscle Maturation, and Disease Modeling
Please fill out the form below to setup a meeting with Hamed at WORD+ 2026
Curi Bio is coming to Italy! 🇮🇹
Our Senior Business Development Manager, Hamed Ghazizadeh, will be traveling through Italy from January 28th - 30th. At Curi Bio we believe that world-class science deserves a "white-glove" approach to our community. Hamed is available to connect with our Italian colleagues to discuss how human-relevant discovery is redefining the path to the clinic.
Whether you are interested in a technical consultation or a demo of our Mantarray™ platform for high-throughput insights into 3D engineered muscle contractility, Hamed is available for 1:1 sessions to see how our biosystems can accelerate your specific drug discovery goals.
Are you based in Italy? Reach out to Hamed Ghazizadeh directly or drop a comment below to coordinate a visit!
Let’s bridge the gap between benchtop discovery and clinical potential together. Ciao!
Please fill out the form below to setup a meeting with Hamed.
Curi Bio team member, Dr. Hamed Ghazizadeh, will be presenting at TOXINS 2026 in Madrid, Spain!
Poster Presentation
Title: Innervation Induces a Distinct Force–Frequency Phenotype in 3D Human Neuromuscular Junction Tissues
Poster #P1.23 | Jan 14 @ 19:30–21:30 | Madrid Marriott Auditorium
Please fill out the form below to setup a meeting with Hamed at TOXINS 2026
Curi Bio’s Nicholas Geisse and Elliot Fisher are headed to the 44th Annual J.P. Morgan Healthcare Conference in San Francisco (January 12-15).
As Curi Bio continues to pursue its mission to accelerate next-generation medicine, we are thrilled to connect with the global leaders, innovative technology creators, and visionaries shaping the future of healthcare.
From AI-integrated discovery engines to our Mantarray 3D engineered muscle tissue platform, we look forward to discussing how human-relevant models are de-risking preclinical pathways and redefining the "golden standard" of drug development.
Please fill out the form below to request a meeting with Nick and/or Elliot at JPM 2026.
Curi Bio team member, Dr. Hamed Ghazizadeh, will be presenting at ELRIG Drug Discovery 2025 in Liverpool, UK!
Find Curi Bio at ELRIG
Poster Presentation
A 3D Human Engineered Muscle Tissue Platform for Longitudinal Muscle Atrophy, Differential Insulin Sensitivity, and Metabolism
Curi Bio team member, Dr. Hamed Ghazizadeh, will be presenting at Safety Pharmacology Society 2025 in Utrecht, Netherlands!
Find Curi Bio at SPS 2025
Poster Presentation
Benchmarking Functional Maturation and Pharmacological Responsiveness in hiPSC-Derived Engineering Heart Tissues for Preclinical Safety Applications
Curi Bio team member, Dr. Hamed Ghazizadeh, will be presenting at the Finnish Organ-on-a-Chip Meeting in Tampere, Finland!
Find Curi Bio at Finnish OOC Meeting
Sponsored Talk
Poster Presentation
Booth
Curi Bio team member, Dr. Nelsa Estrella, will be presenting at the 2025 World Muscle Society in Vienna, Austria!
Find Curi Bio at WMS 2025
Poster Presentation
Innervation Induces a Distinct Force–Frequency Phenotype in 3D Human Neuromuscular Junction Tissues
Curi Bio will be presenting at Frontiers in Myogenesis: Innovations in Myogenesis, From Molecular Mechanisms to Therapeutic Interventions in Sunriver, Oregon, USA!
Find Curi Bio
Poster Presentation
A 3D Human Engineered Muscle Tissue Platform for Longitudinal Muscle Atrophy, Differential Insulin Sensitivity, and Metabolism
Curi Bio will be attending the Obesity Drug Development Summit Europe in Barcelona, Spain!
Contact us to setup a meeting while you’re there!
Curi Bio team member, Dr. Hamed Ghazizadeh, will be exhibiting at the European Muscle Conference in Amsterdam, Netherlands!
Find Curi Bio at EMC 2025
Sponsored Talk
Sunday, September 21 at 15:15
Modeling MYBPC3 Hypertrophic Cardiomyopathy with a 3D Human Engineered Heart Tissue Platform
Poster Presentation
A 3D Human Engineered Muscle Tissue Platform for Longitudinal Muscle Atrophy, Differential Insulin Sensitivity, and Metabolism
Poster Presentation
Benchmarking Functional Maturation and Pharmacological Responsiveness in hiPSC-derived Engineered Heart Tissues for Preclinical Applications
Connect with Curi Bio in-person at BIO International Convention in Boston, MA!
Reach out at contact@curibio.com to setup a meeting.
Looking forward to seeing you there!
Connect with Curi Bio in-person at Microphysiological Systems (MPS) World Summit 2025 in Brussels, Belgium!
Sponsored Session – June 12 at 8:00am – Maritime Room, Maison de la Poste, Tour & Taxis
”Positive Force-Frequency Relationship in iPSC-derived Engineered Heart Tissues”
Poster Presentation – “A Novel Functional In Vitro 3D iPSC-Derived Neuromuscular Junction Model for Investigating Botulinum Neurotoxin Activity and Neuromuscular Disease”
Booth #403
Reach out at contact@curibio.com to setup a meeting.
Looking forward to seeing you there!
Connect with Curi Bio in-person at CLIMB Research Symposium in San Francisco, CA!
Reach out at contact@curibio.com to setup a meeting.
Looking forward to seeing you there!
Join Curi Bio and Cytokinetics for an exciting workshop dedicated to advanced human 3D engineered muscle tissues in disease modeling, drug discovery, and regenerative medicine. The event will feature a balance of informative scientific talks on skeletal muscle, cardiac, and neuromuscular junction models and a hands-on exploration of Curi Bio’s cutting-edge instruments.
Experience technical demonstrations that showcase tissue engineering best practices as well as guided data analysis and interpretation.
Explore the schedule and other details on our workshop page. For any questions or comments, please don’t hesitate to contact us.
Thursday, May 29, 2025
Cytokinetics Headquarters
350 Oyster Point Blvd, South San Francisco, CA 94080
![[Live Webinar] Engineering Human Systems: Scalable and Functional 3D Neuromuscular Junction Models](https://images.squarespace-cdn.com/content/v1/5ea9dcad38347f7b8405d2f9/1774481893429-77O4KM25D1QTB5ZY4383/Curi-Bio-webinar-newsletter-images-2026-04_header+1.png)
![[Live Webinar] Bridging the Translational Gap: Engineering Mature 3D Human Skeletal Muscle for Metabolic Research](https://images.squarespace-cdn.com/content/v1/5ea9dcad38347f7b8405d2f9/1771449028797-ZMBQJO1FWBSGZ2PODKKE/Curi-Bio-webinar-newsletter-header-2026-03-02.png)
![[Live Webinar] Accelerating Discovery: Quantifying Human-Relevant 3D Tissue Function into Decision-Enabling Insights](https://images.squarespace-cdn.com/content/v1/5ea9dcad38347f7b8405d2f9/1768342595265-DC4JGV3G2T5V6H1Z8SW4/2026-events_FEB+Webinar.png)
![[San Francisco Workshop] Advancing Drug Discovery with Human 3D Engineered Muscle Tissues](https://images.squarespace-cdn.com/content/v1/5ea9dcad38347f7b8405d2f9/1745529471534-PVAI8T4HURGPQWSMX420/San-Francisco-Workshop_Curi-Bio_social_website-events-page-image.png)